TrialPanorama/TrialPanorama-database huggingface dataset:
Study 36379880 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 36379880 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 36381503 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 36382108 — Predictive Biomarker (PRD): DRD2 mRNA
Genes: DRD2
Study 36382108 — Safety Biomarker (SAF): DRD2
Study 36382130 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study 36382130 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 36382130 — Monitoring Biomarker (MOI): Cell-free DNA
Study 36382554 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36383021 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 36383021 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 36383730 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 36383907 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 36383907 — Predictive Biomarker (PRD): CDH3 mRNA
Genes: CDH3; CDHP
Study 36383907 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 36384095 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 36384443 — Predictive Biomarker (PRD): GHR mRNA
Genes: GHR
Study 36385011 — Predictive Biomarker (PRD): IFNLR1 mRNA
Genes: IFNLR1; IL28RA; LICR2
Study 36385120 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 36385536 — Predictive Biomarker (PRD): PSMB9 mRNA
Genes: PSMB9; LMP2; PSMB6i; RING12
Study 36385536 — Predictive Biomarker (PRD): PSMB8 mRNA
Genes: PSMB8; LMP7; PSMB5i; RING10; Y2
Study 36386418 — Monitoring Biomarker (MOI): HBV DNA
Study 36386456 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 36386456 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 36387967 — Safety Biomarker (SAF): Hyaluronic acid
Study 36389766 — Safety Biomarker (SAF): Interleukin 1
Study 36394867 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 36394867 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 36395401 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 36395401 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 36395818 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 36396301 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 36396416 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study 36396665 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36396665 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 36396665 — Surrogate Endpoint (SUR): Pathological complete response
Study 36396738 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 36398319 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 36398319 — Predictive Biomarker (PRD): CD69 mRNA
Genes: CD69; CLEC2C
Study 36398319 — Predictive Biomarker (PRD): CRIM1 mRNA
Genes: CRIM1; S52; UNQ1886/PRO4330
Study 36398319 — Predictive Biomarker (PRD): IPO7 mRNA
Genes: IPO7; RANBP7
Study 36398439 — Pharmacodynamic Biomarker (PDY): T-lymphocyte activation antigen CD86
Genes: CD86; CD28LG2
Study 36398439 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 36398439 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 36398439 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 36398439 — Pharmacodynamic Biomarker (PDY): Human leukocyte antigen DR
Study 36398903 — Surrogate Endpoint (SUR): Blood pressure
Study 36399037 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 36399068 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 36399068 — Safety Biomarker (SAF): RAS pathway
Study 36399070 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 36399172 — Predictive Biomarker (PRD): FKRP mRNA
Genes: FKRP
Study 36399997 — Predictive Biomarker (PRD): GGN mRNA
Genes: GGN
Study 36399997 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 36400018 — Monitoring Biomarker (MOI): Cell-free DNA
Study 36400018 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 36400069 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 36400106 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36400531 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 36401081 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 36401732 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36401732 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 36401732 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 36401732 — Predictive Biomarker (PRD): Hormone receptor
Study 36401886 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 36402146 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 36402146 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 36402456 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 36402456 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 36403862 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 36404274 — Predictive Biomarker (PRD): PPA1 mRNA
Genes: PPA1; IOPPP; PP
Study 36404403 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 36404708 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 36404708 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 36406365 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study 36406817 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 36408618 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 36409100 — Predictive Biomarker (PRD): MEA1 mRNA
Genes: MEA1; MEA
Study 36409740 — Surrogate Endpoint (SUR): Bone mineral density
Study 36410013 — Monitoring Biomarker (MOI): Mitochondrial frataxin
Genes: FXN; FRDA; X25
Study 36410207 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36410797 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 36411081 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 36411081 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 36411217 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 36411217 — Predictive Biomarker (PRD): AKT2 mRNA
Genes: AKT2
Study 36411966 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study 36412064 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 36412278 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 36413080 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36413141 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 36413418 — Predictive Biomarker (PRD): NAGLU mRNA
Genes: NAGLU; UFHSD1
Study 36413436 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 36414316 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 36414316 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 36416136 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 36416136 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study 36416136 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 36416874 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 36416874 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 36417675 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study 36418127 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 36418966 — Monitoring Biomarker (MOI): Urokinase plasminogen activator surface receptor
Genes: PLAUR; MO3; UPAR
Study 36419980 — Predictive Biomarker (PRD): MCIDAS mRNA
Genes: MCIDAS; IDAS; MCI; MCIN
Study 36422811 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36423588 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 36423925 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 36424360 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 36424360 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 36424628 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 36424628 — Surrogate Endpoint (SUR): Serum creatinine
Study 36424756 — Predictive Biomarker (PRD): DRD2 mRNA
Genes: DRD2
Study 36424756 — Predictive Biomarker (PRD): ANKK1 mRNA
Genes: ANKK1; PKK2; SGK288
Study 36426287 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 36426287 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 36426287 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 36426808 — Surrogate Endpoint (SUR): Pathological complete response
Study 36427162 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 36427162 — Surrogate Endpoint (SUR): Platelet count response
Study 36427183 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 36427183 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36428744 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 36428744 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 36428784 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 36429387 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 36433829 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 36434733 — Safety Biomarker (SAF): RYR1
Genes: RYR; PPP1R137
Study 36434733 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 36434733 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36434733 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study 36435952 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36436128 — Predictive Biomarker (PRD): Hormone receptor
Study 36436279 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 36436423 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 36436423 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36436423 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 36436542 — Predictive Biomarker (PRD): ASXL1 mRNA
Genes: ASXL1; KIAA0978
Study 36436542 — Predictive Biomarker (PRD): ZRSR2 mRNA
Genes: ZRSR2; U2AF1-RS2; U2AF1L2; U2AF1RS2; URP
Study 36436542 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study 36436542 — Predictive Biomarker (PRD): TET2 mRNA
Genes: TET2; KIAA1546; Nbla00191
Study 36436542 — Predictive Biomarker (PRD): U2AF1 mRNA
Genes: U2AF1; U2AF35; U2AFBP; FP793
Study 36436542 — Predictive Biomarker (PRD): DNMT3A mRNA
Genes: DNMT3A
Study 36436542 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 36436615 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study 36436704 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 36436827 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study 36437418 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 36437469 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36437696 — Predictive Biomarker (PRD): 14-3-3 protein sigma
Genes: SFN; HME1
Study 36438589 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 36438959 — Predictive Biomarker (PRD): LTB4R mRNA
Genes: LTB4R; BLT; BLT1; BLTR; CMKRL1; GPR16; P2RY7
Study 36438959 — Predictive Biomarker (PRD): SYNM mRNA
Genes: SYNM; DMN; KIAA0353; SYN
Study 36438959 — Predictive Biomarker (PRD): SLC40A1 mRNA
Genes: SLC40A1; FPN; FPN1; IREG1; SLC11A3; MSTP079
Study 36438959 — Predictive Biomarker (PRD): SIGLEC1 mRNA
Genes: SIGLEC1; SN
Study 36438959 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study 36438959 — Predictive Biomarker (PRD): CHIC2 mRNA
Genes: CHIC2; BTL
Study 36440097 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 36441357 — Surrogate Endpoint (SUR): Hematologic response
Study 36441436 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 36441436 — Predictive Biomarker (PRD): Hormone receptor
Study 36441715 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 36441798 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36441798 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 36441798 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 36441798 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 36442282 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36442353 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 36443208 — Predictive Biomarker (PRD): CELSR2 mRNA
Genes: CELSR2; CDHF10; EGFL2; KIAA0279; MEGF3
Study 36443208 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 36443208 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 36443208 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 36443816 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 36443816 — Monitoring Biomarker (MOI): Cell-free DNA
Study 36444227 — Surrogate Endpoint (SUR): Hematologic response
Study 36444319 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 36444331 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 36445230 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36445410 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study 36445410 — Predictive Biomarker (PRD): CCL22 mRNA
Genes: CCL22; MDC; SCYA22; A-152E5.1
Study 36445410 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 36445668 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 36445944 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study 36449695 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36450385 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 36450385 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 36450385 — Predictive Biomarker (PRD): ENTPD1 mRNA
Genes: ENTPD1; CD39
Study 36450385 — Predictive Biomarker (PRD): STAT5A mRNA
Genes: STAT5A; STAT5
Study 36450763 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study 36450763 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36451162 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 36451198 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 36451242 — Surrogate Endpoint (SUR): Blood pressure
Study 36451242 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 36451311 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 36451312 — Predictive Biomarker (PRD): MIA mRNA
Genes: MIA
Study 36451848 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 36451848 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study 36452901 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 36452951 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 36453450 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 36453450 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 36453656 — Surrogate Endpoint (SUR): Blood pressure
Study 36455049 — Predictive Biomarker (PRD): SMO mRNA
Genes: SMO; SMOH
Study 36456014 — Surrogate Endpoint (SUR): Blood pressure
Study 36456068 — Surrogate Endpoint (SUR): Serum sodium
Study 36456072 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 36456573 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 36456573 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36456835 — Predictive Biomarker (PRD): ANGPTL3 mRNA
Genes: ANGPTL3; ANGPT5; UNQ153/PRO179
Study 36457575 — Predictive Biomarker (PRD): IGF1R mRNA
Genes: IGF1R
Study 36457825 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 36457825 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Chitinase-3-like protein 1
Genes: CHI3L1
Study 36457860 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 36458825 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 36459100 — Surrogate Endpoint (SUR): Blood pressure
Study 36459243 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 36459255 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 36459255 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study 36459284 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 36459673 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 36459691 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study 36459994 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 36460794 — Predictive Biomarker (PRD): SPHK2 mRNA
Genes: SPHK2; SK2
Study 36461061 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 36461157 — Predictive Biomarker (PRD): CLN3 mRNA
Genes: CLN3; BTS
Study 36461912 — Predictive Biomarker (PRD): RB1
Genes: RB; PPP1R130
Study 36461942 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 36463104 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36463104 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 36463160 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 36463457 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study 36464141 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36464714 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study 36464928 — Surrogate Endpoint (SUR): Blood pressure
Study 36466423 — Safety Biomarker (SAF): Lactotransferrin
Genes: LTF; GIG12; LF
Study 36467452 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 36467452 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study 36469077 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 36469321 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 36469321 — Predictive Biomarker (PRD): IRAK1 mRNA
Genes: IRAK1; IRAK
Study 36469321 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 36469840 — Predictive Biomarker (PRD): WEE1 mRNA
Genes: WEE1
Study 36469915 — Surrogate Endpoint (SUR): Blood pressure
Study 36470418 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 36470546 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 36470974 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 36471222 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36471891 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 36472162 — Predictive Biomarker (PRD): LAMA1 mRNA
Genes: LAMA1; LAMA
Study 36472300 — Surrogate Endpoint (SUR): Blood pressure
Study 36472536 — Predictive Biomarker (PRD): AZIN2 mRNA
Genes: AZIN2; ADC; KIAA1945; ODCP
Study 36472728 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 36473121 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36473121 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 36473121 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 36473126 — Predictive Biomarker (PRD): GLS2 mRNA
Genes: GLS2; GA
Study 36473143 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 36473198 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 36473198 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 36473633 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study 36474017 — Predictive Biomarker (PRD): 40S ribosomal protein S6
Genes: RPS6; OK/SW-cl.2
Study 36474257 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 36474435 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study 36474435 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 36475018 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36475777 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 36476970 — Surrogate Endpoint (SUR): Blood pressure
Study 36477031 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study 36477555 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 36477813 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study 36477870 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 36477870 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study 36477870 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 36477975 — Predictive Biomarker (PRD): RARA mRNA
Genes: RARA; NR1B1
Study 36478334 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study 36479110 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 36480111 — Surrogate Endpoint (SUR): Blood pressure
Study 36480395 — Predictive Biomarker (PRD): LPP mRNA
Genes: LPP
Study 36480463 — Predictive Biomarker (PRD): SLPI mRNA
Genes: SLPI; WAP4; WFDC4